"We are witnessing many instances where pharma companies are shrinking to grow.”

Due to high unmet medical need, oncology is set to remain as the number one therapeutic area globally in the coming years. France has traditionally…

Noel Heaney, general manager of BMS Biologics Ireland, provides an overview of BMS in Ireland, its exciting new USD 900 million biologics facility in…

The GM of France for Bristol-Myers Squibb (BMS) discusses becoming a “diversified biopharma company”, their commitment to remaining a model of…

Automation and consolidation have affected pharmaceutical companies worldwide, and Puerto Rico is no exception. The island has benefited from the…

The country manager of a leading specialty care bio-business reveals how the economic and geo-social fundamentals in Romania are highly attractive…